Int. J. Infect. Dis. 2020 Jan 28
Immune response to different types of hepatitis B vaccine booster doses 2 to 32 years after the primary immunization schedule and its influencing factors.
Zhao YL, Pan LL, Hao ZY, Jin F, Zhang YH, Li MJ, Zhang XJ, Han BH, Zhou HS, Ma TL, Wang F, Ma JC, Shen LP, Li Q
To assess the immune effect of different types of hepatitis B vaccine (HepB) booster doses 2 to 32 years after primary immunization, explore the influ ...
Read More
Source: PubMed
Basic Clin Androl
The detection of canine anti-sperm antibody following parenteral immunization of bitches against homogenized whole sperm.
Esmailnejad A, Nikahval B, Mogheiseh A, Karampour R, Karami S
The development of a canine-specific method of immunocontraception is one of the non-invasive controlling strategies for humanely decreasing the dog p ...
Read More
Source: PubMed
Vaccine 2020 Jan 23
Use of tetanus-diphtheria (Td) vaccine in children 4-7 years of age: World Health Organization consultation of experts.
Desai S, Scobie HM, Cherian T, Goodman T
For lifetime protection against diphtheria and tetanus, the World Health Organization (WHO) recommends six doses of diphtheria and tetanus containing ...
Read More
Source: PubMed
Neural Regen Res
Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019.
Martinez B, Peplow PV
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. The disability caused by inflammatory demyelination cl ...
Read More
Source: PubMed
Hum Vaccin Immunother 2020 Jan 17
Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial.
Valéa I, Adjei S, Usuf E, Traore O, Ansong D, Tinto H, Owusu Boateng H, Some AM, Buabeng P, Vekemans J, Kotey A, Vandoolaeghe P, Cullinane M, Traskine M, Ouedraogo F, Sambian D, Lievens M, Tahita MC, Jongert E, Lompo P, Idriss A, Borys D, Ouedraogo S, Prempeh F, Schuerman L, Sorgho H, Agbenyega T
RTS,S/AS01E malaria vaccine contains the hepatitis B virus surface antigen and may thus serve as a potential hepatitis B vaccine. To evaluate the impa ...
Read More
Source: PubMed
